Target intelligence / Profile preview

Calcineurin (CN)

Target
CN
Molecular classification
Enzyme, Serine/Threonine Protein Phosphatase
01

Overview

Calcineurin is a highly conserved, calcium (Ca²⁺)- and calmodulin-dependent serine/threonine protein phosphatase that plays a central role in cellular signal transduction, especially in immune function and cardiovascular physiology. It is a heterodimer composed of a catalytic subunit (Calcineurin A) and a regulatory subunit (Calcineurin B). Calcineurin dephosphorylates specific substrates in response to increased intracellular Ca²⁺ levels, with a key function being the activation of T cells via NFAT dephosphorylation. It is a target for immunosuppressant drugs like cyclosporin A and tacrolimus, used to prevent organ transplant rejection and treat autoimmune diseases. Dysregulation of calcineurin is implicated in neurodegenerative and cardiovascular diseases.

Other names
Protein Phosphatase 3PP3CaN
02

Mechanism of action

Calcineurin inhibitors (cyclosporin A and tacrolimus) bind to cyclophilin or FKBP12, respectively, and the resulting complex inhibits calcineurin activity.

03

Biological functions

Signal transductionImmune activationT-cell signalingVascular regulationCardiac regulationNeural regulationSynaptic plasticityCalcium signaling modulation
04

Disease associations

Organ transplant rejectionAutoimmune diseasesNeurodegenerative diseasesParkinson’s diseaseSynucleinopathiesCardiovascular disease
05

Safety considerations

Immunosuppression-related side effects (e.g., increased risk of infection, nephrotoxicity)Potential for neurotoxicity in some contextsAberrant activation/inhibition can be harmful depending on the specific disease context
06

Interacting drugs

Cyclosporin A

1 more in the full profile.

Beyond the preview

Go deeper on Calcineurin (CN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcineurin (CN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call